ViiV’s HIV Drug, Tivicay, Launched in the UK

diagnosis Tivicay, Launched in the UK” src=”” width=”164″ height=”147″ />HIV patients in the UK will from this week have another treatment option after ViiV Healthcare announced the launch of their once-daily drug, Tivicay (dolutegravir). The integrase inhibitor was approved in Europe last month for HIV-1 in a broad patient population of treatment-naive and treatment-experienced adults

Continue Reading